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OvariectomyInsulin resistance of skeletal muscle glucose transport due to prolonged loss of ovarian function in ovariecto-
mized (OVX) rats is accompanied by other features of the metabolic syndrome and may be confounded by
increased calorie consumption. In this study, we investigated the role of calorie consumption in the development
of insulin resistance in OVX rats. In addition, we examined the cellular mechanisms underlying skeletal muscle
insulin resistance in OVX rats. Female Sprague-Dawley rats were ovariectomized (OVX) or sham-operated
(SHAM). OVX rats either had free access to food, pair feeding (PF) with SHAM or received a 35% reduction in
food intake (calorie restriction; CR) for 12 weeks. Compared with SHAM, ovariectomy induced skeletal muscle
insulin resistance, which was associated with decreases (32–70%) in tyrosine phosphorylation of the insulin re-
ceptor and insulin receptor substrate-1 (IRS-1), IRS-1 associated p85 subunit of phosphatidylinositol 3-kinase
(PI3-kinase), and Akt Ser473 phosphorylation whereas insulin-stimulated phosphorylation of IRS-1 Ser307,
SAPK/JNK Thr183/Tyr185, and p38 mitogen-activated protein kinase (MAPK) Thr180/Tyr182 was increased
(24–62%). PF improved the serum lipid proﬁle but did not restore insulin-stimulated glucose transport, indicating
that insulin resistance in OVX rats is a consequence of ovarian hormone deprivation. In contrast, impaired insulin
sensitivity and defective insulin signalingwere not observed in the skeletalmuscle of OVX+CR rats. Therefore, we
provide evidence for the ﬁrst time that CR effectively prevents the development of insulin resistance and impaired
insulin signaling in the skeletal muscle of OVX rats.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The insulin resistance syndrome is a condition characterized by in-
sulin resistance of skeletal muscle glucose metabolism and is accompa-
nied by several metabolic and cardiovascular abnormalities, including
central obesity, dyslipidemia, essential hypertension, hyperinsulinemia,
and glucose intolerance [1]. The pathophysiology of the insulin resis-
tance syndrome is complex and involves several factors. Aging is a
major factor in both men and women. In women, the systemic loss of
ovarian function at menopause is associated with an increase in the
amount of visceral fat [2,3], a higher prevalence of atherogenic lipid pro-
ﬁles, insulin resistance and type 2 diabetes [4,5]. As women often spend
nearly one third of their lives in the postmenopausal state, understand-
ing how ovarian hormone depletion contributes to the regulation of glu-
cose metabolism could provide essential information toward reducing
the incidence of insulin resistance and type 2 diabetes. Ovariectomized
(OVX) animals have been used as a model for human menopause and
for studying themetabolic consequences due to loss of ovarian function.
We have previously reported that prolonged (12 weeks) ovariectomyy, Faculty of Science, Mahidol
l.: +66 2 201 5504; fax: +66
wan).
rights reserved.leads to the development of a systemic metabolic condition, including
increased visceral fat accumulation, an abnormal serum lipid proﬁle, im-
paired glucose tolerance, and defective insulin action on skeletal muscle
glucose transport [6]. As ovariectomy results in increased daily food in-
take and promotes weight gain [6–8], the consequences of ovarian hor-
mone deprivation in obesity and insulin resistance are complicated by
the effects of increased calorie intake. Thus, it remains unknownwheth-
er themetabolic defects that result from ovariectomy are confounded by
ovariectomy-induced hyperphagia.
It is well documented that a 25–40% caloric restriction (CR) diet
(below ad libitum intake) enhances insulin sensitivity in both
insulin-sensitive and insulin-resistant skeletal muscle [9–13]. The
underlying molecular process responsible for the enhanced insulin
sensitivity appears to be associated with increased activation of certain
insulin signaling elements [9–13]. However, the beneﬁts of calorie re-
striction on insulin action in rat skeletal muscle under prolonged ovar-
ian hormone depletion have not been determined.
Insulin enhances cellular metabolic functions mainly through the
phosphatidylinositol 3-kinase (PI3-kinase) pathway and stimulates
mitogenic effects via the mitogen-activated protein kinase (MAPK)
signaling pathway [14,15]. Accumulating evidence indicates a con-
nection between the MAPK pathway and insulin resistance in skeletal
muscle [16,17]. To date, no study has reported the cellular mecha-
nisms underlying the insulin-resistant state in skeletal muscle
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tion. It is, therefore, unknown whether the insulin-dependent signal-
ing elements in skeletal muscle are affected. In this context, the aims
of this study were: 1) to investigate whether the insulin resistance in
OVX rats is directly attributed to ovarian hormone depletion or is sec-
ondary to increased caloric intake; 2) to examine the effects of calorie
restriction on the insulin-resistant condition in OVX rats; and 3) to
examine whether the insulin resistance of glucose transport in skeletal
muscle of OVX rats is associated with alterations in signalingmolecules
involved in the skeletal muscle glucose transport system. To address
these issues, a number of metabolic characteristics, including glucose
tolerance, insulin-stimulated skeletal muscle glucose transport, serum
lipid proﬁle, and visceral fat accumulation were determined in OVX
rats that received a pair feeding diet (PF) diet or calorie restriction
(CR). In addition,we evaluated the protein expression and functionality
of speciﬁc elements of the PI3-kinase andMAPK pathways including in-
sulin receptor (IR), insulin receptor substrate-1 (IRS-1), the p85 subunit
of PI3-kinase, Akt, c-Jun NH2-terminal kinase (SAPK/JNK), and p38
MAPK.
2. Materials and methods
2.1. Animal treatments
Animal procedures were approved by the Animal Care and Use
Committee, Faculty of Science, Mahidol University, in accordance
with the International Guiding Principles for Biomedical Research In-
volving Animals of CIOMS. Eight-week-old female Sprague-Dawley
rats, weighing between 180 and 200 g, supplied by the National Lab-
oratory Animal Center, Thailand, were individually housed in an
8×10 in. hygienic hanging cage at the Center of Animal Facilities, Fac-
ulty of Science, Mahidol University. The housing unit was maintained
at 22 C with a 12/12-hour light/dark cycle (light on from 0600 to
1800 h). The rats were randomly assigned to either sham operation
(SHAM, n=10) or bilateral ovariectomy (n=30). Surgery was per-
formed under anesthesia through bilateral skin incisions at the lower
back. Animals were allowed to recover for 7 days after surgery. Body
weight was monitored every other day. The amount of food intake of
each animal was measured over a 24 h period using a metabolic cage
(Model 3701 M081, Tecniplast, Italy), and themeasurementswere con-
ducted at least 3 times per week. Ovariectomized animals were further
divided into 3 groups: OVX-control (OVX, n=10), pair-fed OVX
(OVX+PF, n=10), or calorie-restricted OVX (OVX+CR, n=10). Rats
in the SHAMandOVX-control groupswere given regular rat chow (Per-
fect Companion, Samutprakarn, Thailand) ad libitum. The average
amount of food consumed by SHAM or OVX groupswas recorded to de-
termine the amount of food given to the OVX+PF or OVX+CR groups
in the following day. The amount of food given to animals in the
OVX+PF group was matched to that consumed by the SHAM group,
whereas animals in the OVX+CR group were given 65% of the amount
of chow consumed by the OVX-control group. Rats in the OVX+PF and
OVX+CR groupswere given a portion of their feed allotment in twope-
riods (50% between 0800 and 0900 h and 50% between 1700 and
1800 h).
2.2. Oral glucose tolerance test
Following a 12-week treatment, an oral glucose tolerance test
(OGTT) was performed on each animal as follows. In the evening
(1800 h) of the day before the test, all rats were food-restricted to
4 g of chow. On the day of the test (0900 h), tail blood was collected
before glucose feeding (1 g/kg body wt) by gavage and at 15, 30, 60,
and 120 min after glucose challenge. Blood sample was mixed with
anticoagulant (18 mM ﬁnal concentration of EDTA) and centrifuged
at 13,000 g at 4 C for 1 min. Plasma was kept at −80 C and used for
the determination of glucose (Gesellschaft fur Biochemica undDiagnostica, Wiesbaden, Germany) and insulin (Linco Research, St.
Charles, MO). Aliquots of plasma at the 0-min time point were kept
frozen and used for subsequent analyses of free fatty acid levels
using an enzymatic kit (BioVision, Inc., Mountain View, CA). Immedi-
ately after the OGTT, each animal was subcutaneously given 2.5 ml of
sterile 0.9% saline to replace ﬂuid loss.
2.3. Measurement of muscle glucose transport activity
Five days after the OGTT, all animals were food-restricted as de-
scribed above. At 0800 h, animals were weighed and anesthetized
with an intraperitoneal administration of a mixture of ketamine
(50 mg/kg body wt) and xylazine (10 mg/kg body wt). Soleus mus-
cles were isolated and prepared for in vitro incubation. The two soleus
muscles were divided into four strips each. To investigate the adap-
tive changes in skeletal muscle signaling and GLUT-4 proteins due
to prolonged ovariectomy and calorie restriction, two non-incubated
soleus strips were quickly frozen in liquid nitrogen for subsequent
analyses. Six fresh soleus strips (~25 mg) were incubated for 60 min
at 37 C in 3 ml of oxygenated Krebs-Henseleit buffer (KHB) supple-
mented with 8 mM D-glucose, 32 mM D-mannitol, and 0.1%
radioimmunoassay-grade bovine serum albumin (Sigma Chemical,
St. Louis, MO). Of these six, three muscle strips were incubated in
the absence of insulin, and the other three strips were incubated in
the presence of a maximally effective concentration of insulin
(2 mU/ml; Human R, Eli Lilly, Indianapolis, IN). The ﬂasks were con-
tinuously gassed with a mixture of 95% O2 and 5% CO2 throughout
the incubation and glucose transport assay. After the ﬁrst incubation
period, four of the soleus strips (two incubated without insulin and
two incubated with insulin) were removed, trimmed of fat and con-
nective tissue, and quickly frozen in liquid nitrogen. These strips
were subsequently used for the determination of signaling elements
in response to insulin activation by immunoblotting and immunopre-
cipitation. The remaining muscle strips were rinsed for 10 min at 37 C
in 3 ml of oxygenated KHB containing 40 mM D-mannitol, 0.1% BSA,
and insulin, if previously present. Muscle strips were incubated for
20 min at 37 C in 2 ml of KHB containing 1 mM 2-[1,2-3H]deoxyglu-
cose (2-DG, 300 μCi/mmol; PerkinElmer Life Sciences, Boston, MA),
39 mM [U-14 C]mannitol (0.8 μCi/mmol; PerkinElmer Life Sciences),
0.1% BSA, and insulin, if previously present. At the end of the incuba-
tion period, the muscle strips were removed, trimmed of excess fat
and connective tissue, and immediately frozen with liquid nitrogen
and weighed. The frozen muscles were solubilized in 0.5 ml of 0.5 N
NaOH, and 10 ml of scintillation cocktail (Ultima Gold™; PerkinElmer
Life Sciences) was added. The speciﬁc intracellular accumulation of
2-DG was determined as described previously [18] using mannitol
to correct for extracellular accumulation of 2-DG. Glucose transport
activity was measured as the intracellular accumulation of 2-DG (in
pmol/mg muscle wet weight/20 min).
2.4. Tissue and blood collection
The plantaris muscle and the liver were collected for the determina-
tion of tissue triglyceride content. Bloodwas collected from the abdom-
inal vein using a 5 ml syringe.Whole bloodwas allowed to clot and then
centrifuged at 3,000 g at 4 C for 20 min to obtain serum,whichwas kept
at -80 C until the determination of serum lipids. Immediately after
blood collection, visceral fat was collected from the superﬁcial area cov-
ering the alimentary tract, and the uterus was removed and weighed.
The heart was removed for the animal euthanasia.
2.5. Biochemical assays
Serum levels of total cholesterol, high-density lipoprotein (HDL)-
cholesterol, and low-density lipoprotein (LDL)-cholesterol were deter-
mined using Dimension RxL Max (DADE Behring, Marburg, Germany).
Fig. 1. Body weight (A) and food intake (B) of sham-operated control (SHAM) and
ovariectomized (OVX) rats without or with pair feeding (PF) or moderate calorie restric-
tion (CR). Measurements of bodyweight and food intake were performed at least 3 times
per week during the experiment, and theweekly average values are presented. Values are
means±SE for 10 animals/group. ¥Pb0.05 SHAM vs. OVX; #Pb0.05 SHAM vs. OVX+PF;
*Pb0.05 OVX vs. all other groups; §Pb0.05 OVX+PF vs. all other groups; †Pb0.05
OVX+CR vs. all other groups.
1053M. Prasannarong et al. / Biochimica et Biophysica Acta 1822 (2012) 1051–1061The triglyceride contents in the liver and plantaris muscle were
assessed using enzymatic kits (BioVision).
2.6. Analyses of signaling elements in skeletal muscle
Muscles were homogenized in ice-cold lysis buffer: 50 mM HEPES
(pH 7.4), 150 mMNaCl, 1 mM CaCl2, 1 mMMgCl2, 2 mM EDTA, 10 mM
NaF, 20 mM sodium pyrophosphate, 20 mM β-glycerophosphate, 10%
glycerol, 1% Triton X-100, 2 mM Na3VO4, 10 μg/ml aprotinin and leu-
peptin, and 2 mM PMSF. After a 20-min incubation on ice, the homoge-
nates were centrifuged at 13,000 g for 20 min at 4 C. Aliquots of
supernatant were frozen at−80 C, and a portion of these homogenates
was used for the determination of total protein (BCA method, Sigma
Chemical). Proteins in the homogenates were separated on 8% or 12%
polyacrylamide gels and transferred electrophoretically onto nitrocellu-
lose paper. Protein blots of samples from incubated and non-incubated
muscles were incubated with the appropriate dilution of commercially
available antibodies against phospho-insulin receptor (IR)/IGF1R
(Tyr1158/Tyr1162/Tyr1163) (Millipore, Billerica, MA), insulin receptor
beta (4B8), phospho-IRS-1 (Ser307), IRS-1, the p85 subunit of
PI3-kinase (Millipore), phospho-Akt (Ser473), Akt, phospho-SAPK/JNK
(Thr183/Tyr185), SAPK/JNK, phospho-p38 MAPK (Thr180/Tyr182), and
p38 MAPK. Protein blots of samples from non-incubated muscles were
also incubated with commercially available antibodies against GLUT-4.
Subsequently, all blots were incubated with goat anti-rabbit or anti-
mouse antibody conjugated with horseradish peroxidase-conjugated
(IgG-HRP) secondary antibody. All antibodies, if not speciﬁed above,
were purchased from Cell Signaling Technology (Beverly, MA). Protein
bands were visualized by enhanced chemiluminescence (PerkinElmer
Life Sciences) on hyper ﬁlm (Amersham Biosciences, Buckinghamshire,
England). Images were digitized, and band intensities were quantiﬁed
using an imaging densitometer (GS-800, Bio-Rad) and Quantity One
software.
For the measurements of tyrosine-phosphorylated IRS-1 (IRS-1/
pY) and IRS-1 associated p85 (IRS-1/p85), immunoprecipitation and
subsequent immunoblotting were performed. The muscle homoge-
nates were diluted to 2 mg/ml (IRS-1/pY) or 3 mg/ml (IRS-1/p85).
Subsequently, 0.5 ml of diluted homogenate was immunoprecipitated
with 25 μl of agarose-conjugated anti-IRS-1 antibody (Millipore).
After an overnight incubation at 4 C, the samples were centrifuged,
and the supernatant was removed. The beads were washed three
times with ice-cold PBS, mixed with SDS sample buffer, and boiled
for 5 min. The proteins were separated by SDS-PAGE on 8% polyacryl-
amide gels andwere transferred to nitrocellulose membranes. Immuno-
blotting for detection of IRS-1/p85was completed as described above for
the detection of the protein expression of p85. For analysis of IRS-1/pY,
the nitrocellulosemembranewas incubated in anti-phosphotyrosine an-
tibody (PY99, Santa Cruz Biotechnology). Thereafter, the membranes
were incubated with secondary goat anti-mouse antibody conjugated
with HRP (Santa Cruz Biotechnology). Protein bands of interest were ex-
posed, visualized, and quantiﬁed as described above.
2.7. Statistical analysis
All values are expressed as means±SE. Differences among groups
were determined by one-way ANOVA with Tukey's post hoc test. Sta-
tistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago,
IL, USA). A value of Pb0.05 was considered to be statistically
signiﬁcant.
3. Results
3.1. Body and tissue weight
A signiﬁcant difference in average body weight between SHAM
and OVX rats was observed starting at week 1 after surgery(Fig. 1A). In weeks 2–13, the body weight of the OVX group continued
to elevate and was signiﬁcantly higher than all other groups. At week
2, the body weights of both OVX+PF and OVX+CR groups were
higher (Pb0.05) than that of the SHAM rats (Fig. 1A). During weeks
3–13, the body weight of the OVX+PF rats was higher (Pb0.05)
than that of the SHAM or OVX+CR group (Fig. 1A). The ﬁnal average
body weight and body weight gain per day of the OVX rats were
higher (Pb0.05) than those of the SHAM rats (Table 1). In contrast,
the weight gains in the OVX+PF and OVX+CR rats were lower by
40% and 59%, respectively, compared with the OVX group (Table 1).
Uterine weights in the three OVX groups were 4–5 fold lower than
that of the SHAM rats (Table 1), indicating the effectiveness of ovari-
ectomy. OVX rats displayed a 69% higher visceral fat content than
SHAM rats (Table 1). However, increased visceral fat accumulation
in OVX rats was suppressed (Pb0.05) in the OVX+PF and OVX+CR
groups by 32% and 44%, respectively.3.2. Food intake
OVX rats had a higher (Pb0.05) average food intake than the other
three groups in weeks 1–13 (Fig. 1B), and the average food intake in
the OVX+CR rats was signiﬁcantly lower than that of the other three
groups during weeks 5–13 (Fig. 1B). The total energy intake was
calculated by multiplying the energy in each gram of rat chow by
the average daily food intake, which was calculated from at least
3 collections in one week during the 12-week experimental period.
Table 1
Initial and ﬁnal body weight, total energy intake, uterine and visceral fat weight, fasting plasma insulin and glucose concentration in sham-operated (SHAM), ovariectomized
(OVX), and OVX rats that undergone pair feeding (OVX+PF) and calorie restriction (OVX+CR).
SHAM OVX OVX+PF OVX+CR
Body weight (g)
Initial weight 231.1±2.8 239.6±2.4 238.1±4.6 238.1±4.8
Final weight 295.3±3.9 390.2±8.4⁎ 330.0±2.4⁎† 296.0±1.6†§
Body weight gain/day (g) 0.77±0.06 1.64±0.09⁎ 1.00±0.04⁎† 0.68±0.05†§
Total energy intake (kcal) 4522±72 5771±142⁎ 4369±20† 3795±50†§
Uterine weight (mg) 522.0±43.9 111.6±8.2⁎ 134.0±20.6⁎ 111.4±10.6⁎
Visceral fat weight (g) 15.7±1.1 26.5±3.5⁎ 17.9±1.7† 14.9±1.2†
Insulin (μU/ml) 8.7±0.6 10.3±0.6 12.4±0.9 11.2±1.2
Glucose (mg/dl) 111.4±2.8 122.9±2.7 124.5±1.9 122.4±3.1
Values are means±SE for 10 animals/group.
⁎ Pb0.05 vs. SHAM group.
† Pb0.05 vs. OVX group.
§ Pb0.05 vs. OVX+PF.
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than that of the SHAM rats and was reduced to 75% and 66% of
the total intake of the OVX rats by pair feeding and calorie restriction,
respectively (Table 1).Fig. 2. Serum lipid levels of sham-operated control (SHAM) and ovariectomized (OVX) r
(B) high-density lipoprotein (HDL) cholesterol; (C) low-density lipoprotein (LDL) cholester
terol (LDL/total). Values are means±SE for 10 animals/group. *Pb0.05 vs. SHAM; †Pb0.053.3. Serum lipid proﬁle
The serum levels of total cholesterol (TC), HDL-cholesterol (HDL),
LDL-cholesterol (LDL), and the HDL and LDL to TC ratios areats without or with pair feeding (PF) or moderate calorie restriction (CR). (A) total;
ol; (D) ratio of HDL to total cholesterol (HDL/total); and (E) ratio of LDL to total choles-
vs. OVX; §Pb0.05 vs. OVX+PF.
Fig. 3. Effects of sham operation (SHAM) and ovariectomy (OVX) without or with pair
feeding (PF) or moderate calorie restriction (CR) on (A) plasma free fatty acid (FFA)
levels, (B) liver triglyceride (TG) content, and (C) TG content in plantaris muscle.
Values are means±SE for 8 animals/group. *Pb0.05 vs. SHAM; †Pb0.05 vs. OVX;
§Pb0.05 vs. OVX+PF.
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resulted in signiﬁcant increases in TC (26%) and LDL (34%) but not
HDL (Fig. 2). Compared to OVX, pair feeding and calorie restriction
did not affect TC or LDL but led to a signiﬁcant reduction (8–10%) in
the LDL/TC ratio. However, pair feeding increased HDL by 15% and
the HDL/TC ratio by 10%, while the highest improvements (Pb0.05)
in HDL (26%) and the HDL/TC ratio (31%) were observed in the OVX
rats with calorie restriction (Fig. 2).
3.4. Plasma free fatty acids (FFAs) and tissue triglycerides (TG)
Elevated FFAs and increased ectopic fat accumulation have been
implicated in the etiology of the insulin-resistant state [19,20]. To
determine the potential role of FFAs and ectopic fat in the insulin-
resistant condition in OVX rats, we assessed the plasma level of
FFAs and the TG content in the liver and the plantaris muscle. The
muscular TG content was measured in the plantaris, due to limited
availability of soleus muscle. Ovariectomy resulted in a 67% increase
(Pb0.05) in plasma FFAs (Fig. 3A) and a 59% increase (Pb0.05) in
the liver TG content (Fig. 3B). The elevation of FFAs in the OVX
rats was reduced 32–37% by pair feeding and calorie restriction.
On the other hand, the liver TG content was lowered (Pb0.05)
only by calorie restriction (Fig. 3B). The TG content in the plantaris
was, however, not signiﬁcantly different among the treatments
(Fig. 3C).
3.5. Whole body insulin action
Data from the OGTT, including plasma levels of glucose and insu-
lin, the area under the curve for glucose (glucose AUC) and insulin
(insulin AUC) and the glucose-insulin (G-I) index, are presented in
Fig. 4. The G-I index was calculated as the product of the respective
glucose and insulin AUCs, and it is inversely related to whole-body in-
sulin sensitivity [21]. Plasma glucose (Fig. 4A) and insulin concentra-
tions (Fig. 4B) were not signiﬁcantly different between the groups
throughout the test, except the insulin level at the 15-min time
point in the OVX rats was higher (Pb0.05) than that in the other
groups. There were no signiﬁcant differences in glucose AUCs
among all experimental groups (Fig. 4C). However, ovariectomy
resulted in a signiﬁcant increase in the insulin AUC compared with
the SHAM group (Fig. 4D). Pair feeding failed to reduce the insulin
AUC, whereas calorie restriction produced a signiﬁcant reduction
(27%). Similarly, the G-I index in the OVX group was 61% higher
than that of the SHAM group (Fig. 4E), and calorie restriction signiﬁ-
cantly reduced the G-I index by 33% (Fig. 4E).
3.6. Insulin action on skeletal muscle glucose transport
Basal and insulin-stimulated glucose transport activities in isolated
soleus are shown in Fig. 5. No signiﬁcant differences in basal 2-DG up-
take were observed among the experimental groups. Compared to the
SHAM group, the insulin-stimulated 2-DG uptake and the insulin-
induced 2-DG transport above basal levels in muscle from OVX rats
were reduced (Pb0.05) by 21% and 35%, respectively. These data clearly
indicate the insulin-resistant state of the skeletal muscle of the OVX
rats. Pair feeding in OVX animals did not produce a signiﬁcant change
in the insulin-stimulated 2-DG transport rate. In contrast, calorie re-
striction enhanced the insulin-mediated 2-DG uptake in OVX rats by
86% (Fig. 5B).
3.7. Expression and functionality of signaling elements in skeletal muscle
To assess the adaptive changes in GLUT-4 protein and signaling el-
ements in response to prolonged estrogen deprivation without and
with dietary manipulation, protein expression and phosphorylation
levels were determined in non-incubated soleus. The proteinexpression levels of IR-β, IRS-1, the p85 subunit of PI3-kinase, Akt,
SAPK/JNK, and p38 MAPK as well as the phosphorylation levels of
IR-β (Tyr1158/Tyr1162/Tyr1163), IRS-1 (Ser307), Akt (Ser473), SAPK/
JNK (Thr183/Tyr185), and p38 MAPK (Thr180/Tyr182) were not differ-
ent among groups (Fig. 6). However, a 12-week period of ovariecto-
my resulted in a reduction (Pb0.05) in the total GLUT-4 protein
level in the soleus by 39% (Fig. 6). There was no signiﬁcant effect
of the pair feeding paradigm on total GLUT-4 protein content,
whereas the reduced GLUT-4 protein level in OVX animals was par-
tially attenuated by calorie restriction (P=0.062 between SHAM vs.
OVX+CR).
3.8. Insulin-stimulated activity of insulin signaling and MAPK in skeletal
muscle
The ability of insulin to activate signaling elements in the PI3-K
and MAPK pathways in skeletal muscle was examined in the incubat-
ed muscle. There were no differences in the protein expression of IR-
β, IRS-1, Akt (Fig. 7), SAPK/JNK 1, SAPK/JNK 2/3, and p38 MAPK
Fig. 4. Glucose (A) and insulin (B) responses during an oral glucose tolerance test and the area under the curve (AUC) for glucose (C) and insulin (D) as well as the glucose-insulin index
(G–I index) (E) in sham-operated (SHAM) and ovariectomized (OVX) rats without or with pair feeding (PF) or moderate calorie restriction (CR). Data for the AUC were calculated from
glucose (A) and insulin (B) responses. The G–I index was the product of glucose AUC and insulin AUC for each individual animal. Values are means±SE for 10 animals/group. *Pb0.05 vs.
SHAM; †Pb0.05 vs. OVX; §Pb0.05 vs. OVX+PF.
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stimulation of tyrosine phosphorylation of IR-β and IRS-1, of IRS-1 as-
sociated with the p85 subunit of PI3-kinase, and of serine phosphor-
ylation of Akt in the soleus muscle of OVX rats was signiﬁcantlyFig. 5. In vitro rates of 2-deoxyglucose (2-DG) uptake in the absence (blank bars) and p
2-deoxyglucose uptake due to insulin (B) in soleus muscle of sham-operated (SHAM) and ov
(CR). Values are means±SE for 10 animals/group. *Pb0.05 vs. SHAM; †Pb0.05 vs. OVX; §Pb0reduced when compared with the SHAM group (Fig. 7). Interestingly,
ovariectomy led to the enhanced activation (Pb0.05) of insulin-
stimulated serine307 phosphorylation of IRS-1 (Fig. 7), Thr183/Tyr185
phosphorylation of SAPK/JNK, and Thr180/Tyr182 phosphorylation ofresence (ﬁlled bars) of insulin (2 mU/ml) (A) and net increases above basal rates of
ariectomized (OVX) rats without or with pair feeding (PF) or moderate calorie restriction
.05 vs. OVX+PF.
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tion blunted the decreases in phosphorylated IR-β and IRS-1/pY, the
IRS-1 associated with the p85 subunit of PI3-kinase and the serine
phosphorylation of Akt (Fig. 7). Such dietary manipulation also abol-
ished the increases in the level of phosphorylation of IRS-1 serine307
(Fig. 7), SAPK/JNK 1, SAPK/JNK 2/3, and p38 MAPK (Fig. 8), thereby
suggesting signiﬁcant improvement of the defective insulin signaling
induced by estrogen deprivation.
4. Discussion
The present study provides evidence that the insulin-resistant
condition observed in OVX rats is primarily a consequence of loss of
ovarian function and is independent of the increased food intake
that accompanies the condition. We have also presented novel infor-
mation that the skeletal muscle of OVX rats is characterized by de-
fects in insulin signaling, including reduced insulin action on the
tyrosine phosphorylation of IR and IRS-1, the IRS-1 associated p85
subunit of PI3-kinase and the serine phosphorylation of Akt, with
concomitant increases being observed in insulin-stimulated SAPK/
JNK and p38 MAPK activity. In addition, the present study is the
ﬁrst to show that the development of insulin resistance and the de-
fective signaling elements in skeletal muscle observed in OVX rats
can be prevented by moderate degree of calorie restriction (~35%
less calorie intake than the OVX group).
Excessive calorie intake is one of the causal factors leading to the
insulin-resistant state and diabetes [22]. With ovarian hormone de-
pletion, OVX rat becomes hyperphagic and gains weight [6–8,23].
Consequently, the metabolic defects occurring after ovariectomy
could be confounded by ovariectomy-induced hyperphagia. In this
study, we assessed the metabolic alterations in OVX rats on a pair
feeding (PF) diet. The amount of total energy intake in the OVX+PF
group is equivalent to a 25% reduction in the total energy intake by
OVX rats. The PF dietary regime reduced visceral fat content and im-
proved the lipid proﬁle, as indicated by higher HDL/TC and lower LDL/
TC ratios. Nevertheless, the OVX+PF rats exhibited a positive energy
state because their body weight gain was signiﬁcantly higher than
that of the SHAM rats. In addition, the increased lipid content in the
liver, increased plasma free fatty acid, impaired glucose tolerance
and defective insulin action on skeletal muscle glucose transport in
OVX rats were not attenuated by pair feeding. Based on these ﬁndings,
it may be concluded that the insulin-resistant condition observed in
OVX rats is primarily a consequence of ovarian hormone deprivation.
A critical role of estrogens in glucose homeostasis has been sup-
ported by clinical and experimental studies. For example, postmeno-
pausal therapy with estrogen alone reduces the incidence of insulin
resistance and type 2 diabetes risks [24–26]. Moreover, insulin resis-
tance develops when there is no estrogen in aromatase-knockout
mice [27] or when estrogen receptor alpha (ERα) is deﬁcient [28,29].
The impaired glucose tolerance and reduced insulin sensitivity in ERα
knockout mice was attributed to hepatic insulin resistance [28], im-
paired insulin action [29] and GLUT-4 expression [30] in skeletal mus-
cle. However, insulin action on glucose transport in rat skeletal muscle
was not affected by acute incubations (10 min) with estradiol [31] but
was increased in skeletal muscle from normal rats after a 3-day treat-
ment with an ERα agonist [32]. In this study, we demonstrated that
insulin-stimulated glucose transport activity was reduced in the skele-
tal muscle of OVX rats with a corresponding reduction in the level of
total GLUT-4 protein expression. As normal activation of the PI3-
kinase pathway is essential for the recruitment of GLUT-4 to facilitate
glucose transport, our ﬁndings regarding the defective insulin stimula-
tion of the tyrosine phosphorylation of IR-β and IRS-1, IRS-1 associated
with p85 of PI3-kinase and the serine phosphorylation of Akt probably
explain the insulin resistance of glucose transport activity observed in
the skeletal muscle of OVX rats. These results are consistent with the
notion that a defect in the proximal step of the insulin signalingpathway results in reduced functionality of the downstream signaling
elements. Therefore, the defective signaling response to insulin stimula-
tion in the muscle of OVX rats where GLUT-4 expression is already im-
paired would aggravate insulin resistance.
In addition to its metabolic functions through the PI3-kinase path-
way, insulin exerts mitogenic effects via the mitogen-activated pro-
tein kinase (MAPK) pathway [14,15]. Several lines of evidence
indicate that MAPKs such as SAPK/JNK and p38 MAPK can negatively
modulate the PI3-kinase pathway [16,17,19,33]. These kinases mainly
phosphorylate serine residues on IRS-1, resulting in reduced activities
of the downstream insulin signaling factors [16,17,19,33]. The differ-
ential responses of the insulin signaling elements and these MAPKs
have been previously reported [33,34]. For example, increased phos-
phorylation of SAPK/JNK with impaired activation of IRS-1 and Akt
in skeletal muscle has been revealed in individuals with insulin resis-
tance [34]. Moreover, de Alvaro et al. [33] found that decreased insu-
lin stimulation of the PI3-kinase pathway in skeletal muscle cells
induced by TNF-α did occur in a p38 MAPK-dependent manner. The
present study demonstrated that the insulin resistance of the
PI3-kinase pathway in OVX rats was accompanied by increased IRS-
1 serine phosphorylation with a corresponding increase in SAPK/
JNK and p38 MAPK activation. This observation seems to support
the concept that intact stimulation of the MAPK pathway by insulin
plays an important role in the development of insulin resistance in
the skeletal muscle of OVX rats. Nevertheless, our observation that
impaired glucose tolerance and skeletal muscle insulin resistance do
exist in OVX+PF rats without an increase in insulin-activated
SAPK/JNK and p38 MAPK is more consistent with the interpretation
that intact stimulation of the MAPK pathway by insulin is not re-
quired for the insulin-resistant condition in OVX rats.
It is well documented that insulin resistance is attributed to nu-
merous factors such as increased visceral fat accumulation, plasma
free fatty acids, and fat deposition in non-adipose tissues [35]. For in-
stance, it has been reported that increased long-chain fatty acyl-CoAs
induce defects in IR-β and IRS-1 functionality [36,37] by activating
serine phosphorylation of these signaling elements [37,38]. Indeed,
we did observe a signiﬁcant increase in plasma free fatty acids, viscer-
al fat content, and triglyceride content in the liver but not the plan-
taris muscle of OVX rats. Accordingly, these metabolic changes may
account, in part, for the insulin-resistant state observed in OVX rats.
In this study, we found that pair feeding reduced visceral fat content
and tended to decrease the level of plasma free fatty acid in OVX rats
without improving whole body or skeletal muscle glucose metabo-
lism. Thus, it appears that visceral fat accumulation and plasma free
fatty acids may not be the primary event leading to the development
of the insulin-resistant condition in OVX rats.
Hepatic triglyceride content is directly correlated with the severity
of insulin resistance in both the liver and skeletal muscle [39–41], in-
dependent of intra-abdominal fat and overall obesity [41]. Increased
lipid content has been reported in the liver of postmenopausal
women [42,43] and OVX rodents [20,44–47] and is associated with
an upregulation of the expression of lipogenic markers [44,48] and a
decrease in fatty acid oxidation [20,44]. Estrogen replacement can
prevent hepatic lipid accumulation [20,44,45] and normalize the al-
tered lipogenesis [44,48] and lipid oxidation [44,45] in the liver of
OVX rodents. Our ﬁndings that the enhanced hepatic triglyceride con-
tent in OVX rats is not attenuated by pair feeding support the idea
that this factor may be important in the development of insulin resis-
tance in OVX rats. This notion is supported by the evidence that he-
patic steatosis is an early event in the development of ovariectomy-
induced insulin resistance and obesity in mice [49].
Although PF did not signiﬁcantly increase insulin sensitivity in
OVX rats, a further reduction in total energy intake (~35% less than
the OVX group) effectively prevented the progression of metabolic
defects, including the insulin-resistant condition at whole body and
skeletal muscle levels of OVX rats. We found that these metabolic
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Fig. 6. Effects of pair feeding (PF) or moderate calorie restriction (CR) on the expressions of signaling proteins IR-β (IR beta), IR-β (Tyr1158/Tyr1162/Tyr1163) phosphorylation (p-IR
beta), IRS-1, tyrosine phosphorylation of IRS-1 (IRS-1/pY), IRS-1 (Ser307) phosphorylation (p-IRS-1 Ser307), the p85 subunit of PI3-K (p85), IRS-1 associated with the p85 subunit of
PI3-K (IRS-1/p85), Akt, Akt (Ser473) phosphorylation (p-Akt Ser473), GLUT-4, SAPK/JNK 1, SAPK/JNK 1 (Thr183/Tyr185) phosphorylation (p-SAPK/JNK 1), SAPK/JNK 2/3, SAPK/JNK 2/3
(Thr183/Tyr185) phosphorylation (p-SAPK/JNK 2/3), p38 MAPK, and p38 MAPK (Thr180/Tyr182) phosphorylation (p-p38 MAPK) in non-incubated soleus muscles from ovariecto-
mized (OVX) rats. For IRS-1/pY and IRS-1/p85, muscle lysate was immunoprecipitated with agarose-conjugated anti-IRS-1 antibody prior to immunoblotting against tyrosine
and p85, respectively. IRS-1/pY and IRS-1/p85 were normalized to IRS-1 protein expression. The rest of the signaling proteins were determined by immunoblot analysis and
were normalized to GAPDH. Data are presented as fold change over the sham-operated (SHAM) group. Representative bands from the autoradiograph are displayed at the top
of the ﬁgure. Values are means±SE for 8–10 animals/group. *Pb0.05 vs. SHAM.
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Fig. 7. Insulin-induced expression of IR-β (IR beta), IR-β (Tyr1158/Tyr1162/Tyr1163) phosphorylation (p-IR beta), IRS-1, tyrosine phosphorylation of IRS-1 (IRS-1/pY), IRS-1 (Ser307)
phosphorylation (p-IRS-1 Ser307), IRS-1 associated with the p85 subunit of PI3-K (IRS-1/p85), Akt, and Akt (Ser473) phosphorylation (p-Akt Ser473) in soleus muscles from SHAM
and ovariectomized (OVX) rats without or with pair feeding (PF) or moderate calorie restriction (CR). Muscles were incubated in the absence (blank bars) or the presence (ﬁlled
bars) of insulin (2 mU/ml). For IRS-1/pY and IRS-1/p85, muscle lysate was immunoprecipitated with agarose-conjugated anti-IRS-1 antibody prior to immunoblotting against tyrosine
and p85, respectively. IRS-1/pY and IRS-1/p85 were normalized to IRS-1 protein expression. The rest of the signaling proteins were determined by immunoblot analysis and were nor-
malized to GAPDH. Data are presented as fold change over the SHAM group. Representative bands from the autoradiograph are displayed at the top of the ﬁgure. Values are means±SE
for 8 animals/group. *Pb0.05 vs. SHAM; †Pb0.05 vs. OVX.
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diminution of visceral fat accumulation, the plasma level of free
fatty acid, and the triglyceride content in the liver. One of the im-
portant ﬁndings in this study is the favorable effect of CR on
insulin-stimulated glucose transport and the signaling elements
in skeletal muscle of OVX rats. Without a signiﬁcant improvement
in the expression of the GLUT-4 protein, calorie restriction fully re-
cuperated the impaired insulin action on skeletal muscle glucose
transport activity in OVX rats. Intriguingly, the improved insulin
action on the functionality of the insulin signaling elements and
glucose transport in skeletal muscle was associated with a signiﬁ-
cant reduction in insulin-stimulated IRS-1 serine phosphorylation.
Because the effect of CR on the insulin signaling pathway includesthe proximal step such as insulin-stimulated IR-β and IRS-1, we
speculate that the favorable effect of CR on skeletal muscle insulin
action is associated with the suppression of hepatic fat accumula-
tion and the plasma free fatty acid level. Therefore, the systemic
improvements as a result of CR could be substantial for the bene-
ﬁcial adaptation from the proximal step of the PI3-kinase pathway
and the enhanced activity of the glucose transport system in skel-
etal muscle.
There are some limitations to this study. The soleus muscle (mainly
slow twitch ﬁbers) was used in this study to demonstrate the effects of
OVX and CR on insulin action and related signaling elements. However,
it remains to be veriﬁed whether the same responses will be observed
in muscles with different ﬁber type composition such as the fast twitch
Fig. 8. Insulin-induced expression of SAPK/JNK 1, SAPK/JNK 2/3, SAPK/JNK 1 and SAPK/JNK 2/3 (Thr183/Tyr185) phosphorylation (p-SAPK/JNK 1), p38 MAPK, and p38 MAPK (Thr180/
Tyr182) phosphorylation (p-p38MAPK) in soleus muscles from SHAM and ovariectomized (OVX) rats without or with pair feeding (PF) or moderate calorie restriction (CR). Muscles
were incubated in the absence (blank bars) or the presence (ﬁlled bars) of insulin (2 mU/ml). Data are presented as fold change over the SHAM group. Results were normalized to
GAPDH. Representative bands from the autoradiograph are displayed at the top of the ﬁgure. Values are means±SE for 8 animals/group. *Pb0.05 vs. SHAM; †Pb0.05 vs. OVX.
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of insulin to assess insulin action on skeletal muscle glucose transport,
the determination of insulin sensitivity with lower doses of insulin in
the physiological range is important and should be addressed in future
investigations.
5. Conclusions
In summary, the present investigation demonstrates for the ﬁrst
time that the resistance to insulin-stimulated skeletal muscle glucose
transport activity in OVX rats is characterized by the impaired insulin
stimulation of IR-β, IRS-1/pY, IRS-1/p85 of PI3-kinase, and Akt with
concomitant enhanced insulin-stimulated SAPK/JNK and p38 MAPK
activity. Pair feeding improved serum lipid proﬁles in OVX rats with-
out a signiﬁcant improvement of insulin action at the whole-body or
skeletal muscle level, suggesting a causal role of ovarian hormone
deprivation in the progression of the insulin-resistant condition. A
further reduction in calorie intake, however, prevents the develop-
ment of skeletal muscle insulin resistance and the defective signaling
in the skeletal muscle of rats undergone prolonged ovariectomy.
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